Jade Biosciences/$JBIO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Jade Biosciences
Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies underway and initiation of a first-in-human trial. Jade's pipeline also includes two undisclosed optimized antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.
Ticker
$JBIO
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
30
ISIN
US0080642061
Website
Jade Biosciences Metrics
BasicAdvanced
$232M
-
-$18.79
-
$84.00
1,166.67%
Price and volume
Market cap
$232M
52-week high
$13.47
52-week low
$6.71
Dividend rate
$84.00
Financial strength
Current ratio
5.806
Quick ratio
5.784
Long term debt to equity
-229.929
Total debt to equity
-229.929
Management effectiveness
Valuation
Price to book
-0.9
Price to tangible book (TTM)
-0.9
Price to free cash flow (TTM)
-0.796
Dividend yield (TTM)
1,166.67%
Growth
Jade Biosciences News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Jade Biosciences stock?
Jade Biosciences (JBIO) has a market cap of $232M as of June 03, 2025.
What is the P/E ratio for Jade Biosciences stock?
The price to earnings (P/E) ratio for Jade Biosciences (JBIO) stock is 0 as of June 03, 2025.
Does Jade Biosciences stock pay dividends?
Yes, the Jade Biosciences (JBIO) stock pays dividends to shareholders. As of June 03, 2025, the dividend rate is $84 and the yield is 1166.67%. Jade Biosciences has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Jade Biosciences dividend payment date?
The next Jade Biosciences (JBIO) dividend payment date is unconfirmed.
What is the beta indicator for Jade Biosciences?
Jade Biosciences (JBIO) does not currently have a Beta indicator.